SCHEMBL8105281

SCHEMBL8105281

CCn1cccc(-c2ccc(N)cc2OC)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.44
▸ GAA P10253 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ TSHR P16473 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ IMPDH2 P12268 1/20 0.38
▸ IMPDH1 P20839 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ P2RX3 P56373 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ RPS6KA2 Q15349 1/20 0.36
▸ NR4A1 P22736 1/20 0.36
▸ BRD4 O60885 2/20 0.36
▸ PDE7A Q13946 3/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ WEE1 P30291 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3685492 0.82 BRD4 (0.43) GAAMAPTKDM4ETSHRMAPK1
SCHEMBL11824740 0.74 ALDH1A1 (0.44) MAPTADORA2AALDH1A1NPC1RAB9A
SCHEMBL30839714 0.73 MAPT (0.59) GAAMAPTKDM4ETSHRMAPK1
SCHEMBL347390 0.73 MAPT (0.59) GAAMAPTKDM4ETSHRMAPK1
Hydrochloric Acid SCHEMBL10604756 0.72 MAPT (0.57) THRBGAAMAPTKDM4ETSHR
SCHEMBL3787198 0.70 ALDH1A1 (0.50) THRBGAAMAPTKDM4ETSHR
SCHEMBL6011530 0.67 MAPT (0.52) THRBGAAMAPTKDM4ETSHR
SCHEMBL30839803 0.67 MAPT (0.52) THRBGAAMAPTKDM4ETSHR
SCHEMBL13923526 0.67 ELANE (0.46) THRBGAAMAPTKDM4ETSHR
SCHEMBL27185970 0.67 MAPT (0.52) THRBGAAMAPTKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198267-B2 Substituted oxazolidinones and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-06-12 — — US disclosed
US-8198267-B2 Substituted oxazolidinones and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-06-12 — — US disclosed
EP-2167499-B1 SUBSTITUTED OXAZOLIDINONES AND USE THEREOF Bayer Pharma AG (DE) 2011-12-14 — — EP disclosed
US-20100298293-A1 SUBSTITUTED OXAZOLIDINONES AND THEIR USE BAYER SCHERING PHARMA ATIENGESELLSCHAFT (DE) 2010-11-25 — — US disclosed
US-20100298293-A1 SUBSTITUTED OXAZOLIDINONES AND THEIR USE BAYER SCHERING PHARMA ATIENGESELLSCHAFT (DE) 2010-11-25 — — US disclosed
WO-2008155069-A2 SUBSTITUTED OXAZOLIDINONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298293-A1 SUBSTITUTED OXAZOLIDINONES AND THEIR USE XDH, OXA1L, PPOX THRB 3910/4885GAA 833/4885MAPT 4810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback